40 Recruiting Studies Using Thiotepa
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Thiotepa
Itacitinib for the Prevention of Graft Versus Host Disease
π M D Anderson Cancer Center β Houston, Texas
Hematologic and Lymphocytic Disorder
View Study & Checklist βA Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
π Memorial Sloan Kettering Cancer Center β New York, New York
Acute Myeloid Leukemia (AML)
View Study & Checklist βCombination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
π Anchorage Associates in Radiation Medicine β Anchorage, Alaska
Lymphoma
View Study & Checklist βBusulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
π M D Anderson Cancer Center β Houston, Texas
Hematopoietic and Lymphoid Cell Neoplasm
View Study & Checklist βTCRΞ±Ξ²-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
π St. Jude Children's Research Hospital β Memphis, Tennessee
Acute Lymphoblastic Leukemia (ALL)
View Study & Checklist βHaplocompatible Transplant Using TCRΞ±/Ξ² Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
π St. Jude Children's Research Hospital β Memphis, Tennessee
Severe Combined Immunodeficiency
View Study & Checklist βProvision of TCRΞ³Ξ΄ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in NaΓ―ve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
π St. Jude Children's Research Hospital β Memphis, Tennessee
Acute Lymphoblastic Leukemia (ALL)
View Study & Checklist βReduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
π Stanford University β Stanford, California
Allogeneic Hematopoietic Cell Transplantation (HCT)
View Study & Checklist βInfusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Acute Biphenotypic Leukemia
View Study & Checklist βPalifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
π Memorial Sloan Kettering Cancer Center β New York, New York
Leukemia
View Study & Checklist βMismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
π Children's Hospital of Alabama β Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist βAllogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple Myeloma
π University of California Davis Comprehensive Cancer Center β Sacramento, California
Recurrent Multiple Myeloma
View Study & Checklist βCD34+ Transplants for Leukemia and Lymphoma
π Baptist Health South Florida/Miami Cancer Institute β Miami, Florida
Leukemia, Myeloid, Acute
View Study & Checklist βDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
View Study & Checklist βTCRΞ±Ξ²-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naΓ―ve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
π St. Jude Children's Research Hospital β Memphis, Tennessee
Hematologic Malignancy
View Study & Checklist βCNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
π Washington University School of Medicine β St Louis, Missouri
Diffuse Large B Cell Lymphoma
View Study & Checklist βMyeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
π Masonic Cancer Center, University of Minnesota β Minneapolis, Minnesota
Neuroblastoma
View Study & Checklist βABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
π University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center β Cleveland, Ohio
Acute Myelogenous Leukemia
View Study & Checklist βLung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
π UPMC Presbyterian β Pittsburgh, Pennsylvania
Idiopathic Pulmonary Fibrosis
View Study & Checklist βCord Blood Transplantation in Children and Young Adults With Blood Cancer
π Memorial Sloan Kettering Cancer Center (All Protocol Activities) β New York, New York
Acute Myelogenous Leukemia
View Study & Checklist βT-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
π Children's Hospital of Pittsburgh of UPMC β Pittsburgh, Pennsylvania
Sickle Cell Anemia
View Study & Checklist βTesting the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
π Children's Hospital of Alabama β Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist βAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
π Hospital de Pediatria "Juan P. Garrahan" Combate de Los Pozos NΒ°1800 CABA β Buenos Aires,
Acute Lymphoblastic Leukaemia
View Study & Checklist βDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
π Children's Hospital of Alabama β Birmingham, Alabama
Ganglioneuroblastoma, Nodular
View Study & Checklist βThiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
π UMPC Hillman Cancer Center β Pittsburgh, Pennsylvania
Acute Lymphocytic Leukemia (ALL)
View Study & Checklist βA Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
π Children's Hospital of Alabama β Birmingham, Alabama
Central Nervous System Nongerminomatous Germ Cell Tumor
View Study & Checklist βOptimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
π The University of Texas M. D. Anderson Cancer Center β Houston, Texas
Hematologic Malignancies
View Study & Checklist βHaploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
π St Jude Children's Research Hospital β Memphis, Tennessee
Sickle Cell Disease
View Study & Checklist βAutologous Stem Cell Transplantation in Patients With Systemic Sclerosis
π Children's Hospital of Pittsburgh of UPMC β Pittsburgh, Pennsylvania
Systemic Sclerosis
View Study & Checklist βPilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
π Alberta Children's Hospital β Calgary, Alberta
CNS Embryonal Tumor
View Study & Checklist βReduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
π UPMC Children's Hospital of Pittsburgh β Pittsburgh, Pennsylvania
Primary Immunodeficiency (PID)
View Study & Checklist βCord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
π Fred Hutch/University of Washington Cancer Consortium β Seattle, Washington
Acute Leukemia of Ambiguous Lineage
View Study & Checklist βNaive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
π Children's Hospital of Los Angeles β Los Angeles, California
Acute Biphenotypic Leukemia
View Study & Checklist βVenetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
π M D Anderson Cancer Center β Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist βIS-free Treg HaploHCT
π Dana Farber Cancer Institute β Boston, Massachusetts
Stem Cell Transplant Complications
View Study & Checklist βOrca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
π City of Hope Medical Center β Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist βPilot Study of Memory-like Natural Killer (ML NK) Cells After TCRΞ±Ξ² T Cell Depleted Haploidentical Transplant in AML
π Washington University School of Medicine β St Louis, Missouri
AML, Childhood
View Study & Checklist βGraft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
π Moffitt Cancer Center β Tampa, Florida
Acute Leukemia
View Study & Checklist βAutologous Stem Cell Transplantation for Crohn's Disease
π UPMC Prebyterian- Adult Gastroenterology β Pittsburgh, Pennsylvania
Crohn's Disease
View Study & Checklist βCD45RA-depleted CD19-CAR T Cell Consolidation After TCRΞ±Ξ²+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
π St. Jude Children's Research Hospital β Memphis, Tennessee
Relapsed Pediatric ALL
View Study & Checklist β